Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
EYTcrTmKeDtu6mRX
